Study of a new drug AVR-48 in healthy volunteers
This study tests a new drug called AVR-48 in healthy volunteers to find out how safe it is and how the body processes it. It's an early-phase trial that may lead to future treatments for infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a healthy adult between 18 and 55 years old
- Be a non-smoker and have not used any nicotine products (including vaping) for at least 3 months
- Have a body mass index (BMI) between 18 and 32, and weigh between 50 and 100 kg
- Be generally healthy with no serious medical conditions
- If you're a woman who could become pregnant, agree to use effective birth control; if you're a man, agree to use contraception and not donate sperm during the study
- Be available for all study visits and procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new oral medication in healthy adults to see how safe it is and how the body handles it. It's an early-stage study, so participants help determine the right dose for future patients.
This trial tests how a new drug, E2086, interacts with other medicines in healthy volunteers. It helps make sure the drug is safe and works properly when combined with common medications.
This trial tests a new experimental drug (ISM4808) in healthy adults to see how safe it is and how the body handles it. It may help researchers learn if the drug is promising for future treatments.
This trial tests different doses of a new study drug in healthy people to see how safe it is and how the body handles it. Participation involves taking the drug and having regular check-ups.
This study tests a new drug called ABBV-243 in healthy adults to see if it is safe and how the body processes it. Participation helps researchers understand the drug before studying it in people with a disease.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
Hear when a new Safety Issues trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.